Law360, New York (June 13, 2013, 7:28 PM EDT) -- The big cats gathered in Washington, D.C., this week, where the U.S. Supreme Court laid down a series of important decisions on human DNA patents, sentencing guidelines, and judicial involvement in plea agreements. Among this week's legal lambs are lawyers for generic-drug makers who succumbed to a nine-figure settlement, and a handful of budget-minded firms that cut loose some colleagues.
Attorney Eric Katz of Mazie Slater Katz & Freeman LLC got a unanimous high-five from U.S. Supreme Court, which backed the decision-making authority of...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.